GNH USA

USA — NDC

TAGRISSO 40 mg/1

TAGRISSO 40 mg tablets are a prescription medication used in the treatment of certain types of non-small cell lung cancer. This medication contains osimertinib,

Osimertinib
TAGRISSO
TABLET, FILM COATED
40 mg/1

Request sourcing

1
Pack/s

What is Osimertinib?

TAGRISSO 40 mg tablets are a prescription medication used in the treatment of certain types of non-small cell lung cancer. This medication contains osimertinib, a targeted therapy designed to inhibit specific mutations in cancer cells. TAGRISSO is manufactured by AstraZeneca Pharmaceuticals LP and is available in a 30-tablet bottle.

What is Osimertinib used for?

TAGRISSO 40 mg tablets are primarily used for the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. Osimertinib, the active ingredient, works by targeting these mutations to help slow the growth and spread of cancer cells. This medication is often prescribed for patients who have tested positive for these mutations, either initially or after other treatments have been tried. TAGRISSO is designed to be taken orally and is part of a broader treatment plan that may include other therapies.

What are the side effects of Osimertinib?

Common effects of TAGRISSO 40 mg tablets may include diarrhea, rash, and dry skin. Some patients may also experience fatigue, nausea, or decreased appetite. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or bothersome effects with a healthcare provider.

What precautions apply to Osimertinib?

TAGRISSO 40 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only and should be taken exactly as prescribed. It is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you have. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before starting TAGRISSO.

What does Osimertinib interact with?

TAGRISSO 40 mg tablets may interact with certain medications, including those that are metabolized by the liver's CYP3A4 enzyme. This can affect how well the medication works or increase the risk of side effects. It is important to avoid grapefruit and grapefruit juice while taking TAGRISSO, as they can interfere with the metabolism of the medication. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently asked questions

What is TAGRISSO used for?+
TAGRISSO is used to treat non-small cell lung cancer with specific EGFR mutations. It is designed to target these mutations to help slow the growth and spread of cancer cells.
How should TAGRISSO be taken?+
TAGRISSO should be taken orally, exactly as prescribed by your healthcare provider. It is important to follow the dosage and administration instructions provided.
What are the common side effects of TAGRISSO?+
Common side effects of TAGRISSO may include diarrhea, rash, dry skin, fatigue, nausea, and decreased appetite. These effects can vary in severity and may not affect everyone who takes the medication.
Can TAGRISSO be taken with other medications?+
TAGRISSO may interact with certain medications, particularly those metabolized by the liver's CYP3A4 enzyme. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.
Is TAGRISSO safe during pregnancy?+
The safety of TAGRISSO during pregnancy has not been established. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before starting TAGRISSO.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Osimertinib
Brand
TAGRISSO
Strength
40 mg/1
Form
TABLET, FILM COATED
Route
ORAL
Pack size
30 TABLET, FILM COATED in 1 BOTTLE (0310-1248-30)
Manufacturer
AstraZeneca Pharmaceuticals LP
Origin
USA

Related products